The history of dialysis teaches us that a reduction in dialysis time in the USA was accompanied by a reduction in life-expectancy Are Lombardy nephrologists going to make the same mistake?
In the 1980s, a surprising result was highlighted by a number of studies evaluating the survival of haemodiaThe EDTA estimates may not be perfectly reliable lysis patients in different countries: European and because of the low reply rate. In contrast all of the 44 Japanese ESRD patients had a better survival than dialysis centres in Lombardy regularly supply data. those treated in the USA [1, 2] . In 1993 the expected Looking at the 1983-1996 data of the Lombardy remaining lifetime for dialysis patients aged 45-65 Registry of Dialysis and Transplantation [6 ] the years was three times higher in Japan than in the USA. decrease in dialysis time stands out a mile: the number Some caution was required when making the compar-of dialysis sessions lasting less than 3 h (three ison because the standardized mortality ratio methods times/week) has increased from 4 to 16.3%, the number used adjust only for age, gender, race, and the cause of those lasting 3-4 h has increased from 55.4 to of end-stage renal disease (and not for comorbidities), 71.6%, and the number of those lasting 4-5 h has but the importance of these data prompted a pro-decreased from 39.9 to 11.8%. However, the survival vocative editorial by Nosé [3] entitled 'Why do we kill of Lombardy patients is still better in comparison with so many patients on hemodialysis in the USA?' The those treated in the USA, even after adjustment for author's conclusion was that USA patients were comorbidities [7, 8] . underdialysed because the substantially inadequate At a time when the USA has shown that it is well reimbursement of haemodialysis procedures in the aware of the risks of reducing treatment time and has USA made it almost impossible to provide sufficient begun to reverse the trend of the eighties which clearly dialysis therapies to patients. An analysis of the dialysis reduced standardized mortality ratio over recent years prescriptions made in 1986 and 1987 [4] found that [9] , and when Japanese are warned not to make the the prescribed level of dialysis in the USA was substan-same mistake as the Americans did in the past, tially lower than in Europe; furthermore, the most Lombardy seems to be going into the opposite direction striking feature of these lower haemodialysis dose was apparently without having any qualms. If we refute the progressive decrease in the duration of dialysis the statement of Hegel and assume that history can sessions, which were 23.5% shorter than in Europe and teach us to avoid repeating dangerous mistakes, we 40% shorter than in Japan (where the reimbursement feel that this is the time for nephrologists in Lombardy was proportional to the duration of dialysis).
(and Europe) to reconsider the issue of duration of dialysis sessions. The best incentive to raise this point is the observation of Charra et al. [10] The history of short dialysis [16 ] , controlled for a long list of comorbid conditions, of a randomly selected national sample of over 2300 The widespread trend towards shortening the duration Medicare ESRD patients. However, in this analysis, of dialysis sessions has been driven by a number of the prescribed treatment time did not significantly factors (the cost/effectiveness ratio, patient-staff concorrelate with the risk of mortality despite the large venience, improved technology), but its justification is sample size and adjustments for comorbid conditions founded on the evolution of scientific knowledge. The and other covariates, and there was not even a suggesintroduction of the concept of the square meter hour tion that a longer treatment time (at the same Kt/V ) hypothesis in 1971 [11] suggested that dialysis time provides any benefit in terms of survival. Furthermore, (the only dialytic parameter that entirely depends on the considered treatment times were those prescribed, prescription) could be shortened with impunity as long which may not always match delivered treatment time. as the dialyser surface area was increased to yield the A possible explanation for this could be that the same surface area×time product.
prescribed dialysis treatments covered a narrow range of 3-4 h; no conclusion can therefore be drawn from these data concerning the possible benefit of 5-8 h
The concept of dialysis quantification ( Kt/V )
treatments (the times used in Tassin [10] ). Consequently, there are currently no conclusive results In 1983 Gotch and Sargent [12] introduced the paramaking it possible to establish whether, for a given meter Kt/V for urea as a predictor of patient outcomes, value of Kt/V, high clearance and a short treatment and this has had an even more important effect on the time is worse or better than low clearance and a long prescription of the duration of dialysis sessions. This treatment time. The only thing that we know for was due to the results of a re-analysis of the data certain is that the risk of mortality inversely correlates provided by the National Cooperative Dialysis Study with the delivered dialysis dose. (NCDS) [13] , the only large-scale prospective study designed to compare patient outcomes after short and long treatment sessions based on different TAC urea. How can the Japanese and Tassin data be Although the correlation between outcome and treat-reconciled with those showing no treatment ment time only showed a non-significant trend (P= time effect? 0.06), there was a close correlation between patient outcomes and Kt/V, which was therefore assumed to
The excellent survival results reported in Japan [1] and be the best means of estimating dialysis adequacy.
by Charra et al. [10] do not conflict with an inverse Given that there was no difference in the way that correlation between mortality and dose: the smaller Kt/V of more than 1.0 was reached, it was assumed size of the Japanese population means that longer that the value of t could be safely reduced provided treatment time is the equivalent of a higher dialysis that K was increased in order to maintain the K×t dose, and the Kt/V reported by Charra in his patients product constant. averaged 1.7. Moreover, since efficiency can vary greatly, treat-
What does adequacy of dialysis actually mean?
ment time is now a meaningless expression of treatment quantity. The ability to increase the solute removal rate has created a conceptual difference between treatAnalysis of the NCDS data clearly shows that a low ment time and treatment 'dose'. A short treatment Kt/V ratio also means an inadequate correction of time is no longer synonymous with less therapy, and acidosis and electrolyte derangement. Furthermore, the long treatment sessions do not necessarily imply more reappraisal of data published by Keshaviah [14] sugsolute removal. However, it is very likely to be so in gests a curvilinear relationship between Kt/V and everyday clinical practice. morbidity. Finally, the impressive results obtained by Charra et al. [10] with very long dialysis sessions (8 h) raise serious doubts about the validity of the asser-Treatment time per se cannot replace the tion thought to justify short dialysis. Is treatment quantification of dialysis adequacy time really an independent determinant of patient outcomes?
It cannot be assumed that treatment time-especially if empirically defined-can replace Kt/V or, more
Effect of treatment time per se
generally, urea kinetics as an index of dialysis adequacy. This is particularly true if the dialysis is quantified on-line without blood and dialysate samThe editorial by Port [15] provides a very enlightening review of the situation. Although the analysis is open pling, and at no extra cost [17] . The problem in prescribing and delivering an adequate dialytic treatto criticism because of the lack of adjustment for comorbid conditions, many reports have suggested ment lies in the correct application of dialysis quantification which, to be successful in clinical practice, that lower morbidity and mortality rates correlate with higher haemodialytic doses. This correlation has been requires a comprehensive approach that acknowledges
adequate salt and water removal, hypertension will usually persist despite the use of antihypertensive medication. Longer dialysis sessions make it possible to
Optimal vs adequate dialysis avoid the high hourly ultrafiltration rates that often cause severe hypotensive episodes that prevent the Central to the evaluation of dialysis adequacy is a attainment of dry body weight. definition of adequate Kt/V, but this is still something of an open question. It is certainly fair to say that The lesson of history and the progress of knowledge today's consensus is that 1.2 is the minimum adequate value of Kt/V. Accepting this value as a definition of
In conclusion, although target Kt/V can be obtained adequate dialysis, and bearing in mind that shortening by means of greater dialytic efficiency and/or a longer dialysis time requires an increase in the rate of solute dialysis time, most of the symptoms experienced by removal in order to maintain a constant Kt/V value, patients during haemodialysis are related to their poor we can try to define the minimum treatment time for tolerance of fluid removal. Prolonging dialysis time delivering this dialysis dose, which of course will makes fluid removal easier and thus not only makes it depend on dialyser urea clearance, the body weight of possible to reach dry body weight and control blood the patient, the operational conditions and last, but pressure, but also allows better correction of electrolyte not least, the possibility of reaching dry body weight.
and acid-base imbalance. Treatment time therefore Moreover, the removal of middle molecules is dependcannot be reduced to below the point at which fluid ent on treatment time but, even more importantly, on removal is associated with an unacceptable increase in the type of membrane.
symptoms. Today, the onset of symptoms while removing interdialytic weight gain is the limiting factor in reducing treatment time. Because of this relationship
Time as a safety factor: the shorter the time, the the search for more efficient dialysers and dialysing greater the risks techniques is futile.
The main lesson of history seems to be that, in order What must be stressed is that the impact of a number to prescribe an adequate dialytic treatment, sufficient of possible risks is greater, the shorter the treatment emphasis must be put on the duration of dialysis per se, time. Because of common errors in applying urea because this factor determines whether dry body weight kinetic modeling, it is very likely that the prescribed can be attained, blood pressure be controlled, and time is often unappropriately short to attain the target cardiovascular morbidity and mortality be reduced. Kt/V and dry body weight. Furthermore, there is often On the other hand, one must avoid the risk of overa difference (and sometimes a large difference) between simplification: if we act on a purely empirical basis, prescribed and delivered dialysis but, because delivered we may lose improvements derived from the progress dialysis is not routinely verified [17] , underdialysis may of knowledge. History teaches us to avoid repeating go unnoticed and thus have deleterious clinical effects the mistakes of the past, but also to keep an open in the long term. This risk is the greater the shorter is mind when true progress occurs. the prescribed treatment time. Obviously, a shorter But at the end we hope that the current most treatment time reduces the 'reserve dose' that can unfortunate trend to shorten the duration of dialysis compensate for the operational imperfections of dia-sessions in Lombardy will not continue in view of the lysis. It is evident that only a prescribed dialysis ample demonstration in the past that short dialysis duration exceeding the minimum defined from a theor-sessions are disadvantageous. etical point of view allows some protection from the risk of dangerously inadequate treatments.
